Coronary disease & ACS

No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial

EuroInterventionPublished Post hoc analysis of the TOTAL randomised trial

Primary result · No-reflowResult — go to the resultOdds ratio 0.95 95% CI 0.71–1.28

Authors' conclusion

In patients with STEMI treated by PCI, thrombectomy did not reduce no-reflow in all patients but may be synergistic with direct stenting. No-reflow is associated with increased adverse clinical outcomes.

Study context

Population
ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI)randomly selected from 10,732
Participants
1,800 patients
Comparison
Thrombectomy vs PCI alone
  • Thrombectomyn = 891
  • PCI alonen = 909reference
Primary endpoint
No-reflow
Methodological detailsangiographic core laboratory analysis
  • Angiographic core laboratory analysis

Primary result

As reported in the abstract

Odds ratio

0.95

95% CI 0.71–1.28

P = 0.76

Events by treatment group

Thrombectomyvs PCI alone
OR 0.95 (95% CI 0.71–1.28); P = 0.76
Overall no-reflow
196 of 1,800 (10.9%)

Further findings

OutcomeThrombectomyPCI aloneOR (95% CI)
No-reflow, direct stenting (subgroup)5.1%9.7%0.50 (0.26–0.96)
Denominator371216

Primary composite outcome (CV death, recurrent MI, cardiogenic shock or NYHA class IV HF) in no-reflow patients · 1 year

Adjusted HR (95% CI)P value
No-reflow1.70 (1.13–2.56)P = 0.01

No-reflow, no direct stenting (subgroup)

No difference between the groups
OR 1.18 1.18 (95% CI 0.82-1.69)
  • 64/504 [12.7%] vs 75/686 [10.9%]
  • Interaction p-value=0.02

Original publication

No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial. EuroIntervention. Published 7 August 2023. doi:10.4244/eij-d-23-00112

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.